rs61734984
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001003787.4(STRADA):āc.508C>Gā(p.Leu170Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000694 in 1,614,006 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. L170L) has been classified as Likely benign.
Frequency
Consequence
NM_001003787.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STRADA | NM_001003787.4 | c.508C>G | p.Leu170Val | missense_variant | 8/13 | ENST00000336174.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STRADA | ENST00000336174.12 | c.508C>G | p.Leu170Val | missense_variant | 8/13 | 1 | NM_001003787.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00358 AC: 545AN: 152188Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00118 AC: 296AN: 251224Hom.: 2 AF XY: 0.000891 AC XY: 121AN XY: 135780
GnomAD4 exome AF: 0.000391 AC: 571AN: 1461700Hom.: 4 Cov.: 31 AF XY: 0.000323 AC XY: 235AN XY: 727162
GnomAD4 genome AF: 0.00360 AC: 549AN: 152306Hom.: 3 Cov.: 32 AF XY: 0.00363 AC XY: 270AN XY: 74472
ClinVar
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | STRADA: BS1, BS2 - |
STRADA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 12, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Polyhydramnios, megalencephaly, and symptomatic epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at